Core Viewpoint - The approval of the "Monkey Zao Chutian San" by the National Medical Products Administration marks a significant milestone for the company, indicating the successful implementation of the simplified registration policy for traditional Chinese medicine in Hong Kong and Macau [1] Company Summary - The company's stock, Bitian Tang (00897), rose by 11.36% to HKD 0.49, with a trading volume of HKD 2.5302 million [1] - The company’s flagship products include the "An Gong Niu Huang Wan" series, the classic "Yang Yin Wan," and the "Monkey Zao Chutian San," which has been a sales champion for ten consecutive years [1] Industry Summary - The approval represents the first product to be granted market access under the newly simplified registration policy for traditional Chinese medicine, highlighting the effectiveness of regulatory changes in the industry [1]
位元堂涨超11% 猴枣除痰散通过简化注册审批政策获批内地上市